The conceptual class of Zfp931 Inhibitors encompasses a diverse array of chemical compounds designed to indirectly modulate the activity or expression of Zfp931 through the alteration of various signaling pathways and cellular processes. Given Zfp931's presumed role as a zinc finger protein involved in transcriptional regulation, the selected inhibitors target mechanisms such as DNA methylation, histone acetylation, and chromatin remodeling. These processes are crucial for the regulation of gene expression and are pathways through which Zfp931 is likely to exert its biological effects.
This approach to identifying potential inhibitors highlights the complexity of transcriptional regulation and the interconnected nature of cellular signaling networks. By targeting key regulatory processes that influence gene expression, such as chromatin accessibility and the activity of transcription factors, these inhibitors offer insights into the biological functions of Zfp931 and its role in cellular processes. Through such exploration, the selected compounds not only facilitate a deeper understanding of Zfp931's involvement in gene expression but also underscore the broader principles of cellular regulation and signal transduction. This methodology exemplifies the potential of targeted chemical intervention to modulate the function of specific proteins indirectly, providing a foundation for further research into the mechanisms of transcriptional regulation and the role of zinc finger proteins like Zfp931 in these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase, potentially affecting chromatin accessibility and gene expression regulated by Zfp931. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferase, potentially altering DNA methylation and impacting Zfp931-regulated gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor, could modify chromatin structure, potentially influencing Zfp931's role in transcriptional regulation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor, might affect methylation patterns of genes regulated by or regulating Zfp931. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor, could disrupt protein-protein interactions, affecting Zfp931's function in transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Selective HDAC inhibitor, potentially modulates chromatin structure, affecting Zfp931 activity. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
BET inhibitor, potentially disrupts Zfp931 interaction with chromatin, affecting its regulatory roles. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Broad-spectrum HDAC inhibitor, potentially influences Zfp931 role in transcriptional regulation. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
BET bromodomain inhibitor, might influence Zfp931-mediated gene regulation through chromatin modification. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $151.00 $461.00 | 1 | |
EZH2 inhibitor, potentially affecting histone methylation, could influence Zfp931's regulatory mechanisms. | ||||||